Table of Contents
Healthcare networks are messy. Years of clinical systems, medical devices, applications, vendors and infrastructure create connections that made sense individually but collectively create far more reach than most organizations would design intentionally. Now add AI agents, and the case for AI agent identity microsegmentation becomes even more pressing.
Why AI Agent Identity Microsegmentation Matters Before Approval Debates Are Settled
An agent can arrive with credentials and access across multiple systems, sometimes without going through the mature intake processes built for people, vendors or medical devices. A capability gets enabled inside an existing platform, or someone stands one up with an API key and a legitimate business need. The technology is moving faster than most governance models, and the agent’s access doesn’t wait for debates about ownership and approval to finish.
Starting With Reach Rather Than Approval
The control itself isn’t new. Identity-based microsegmentation limits what an identity can reach, and the principle is the same whether that identity belongs to a nurse, a workload, an ultrasound machine that can’t be patched, or an AI agent. Least privilege doesn’t stop being relevant because the identity is autonomous.
Why the Enforcement Point Matters for AI Agent Identity Microsegmentation
Some of the hardest healthcare assets to protect are also the ones where installing another endpoint control isn’t practical, and a process with local administrative rights may be able to disable software running beside it. It cannot disable a segmentation policy enforced by the network it is using.
Addressing the Budget Objection
The fair objection is money. Healthcare doesn’t have an unlimited technology budget, and every security investment competes with clinical, operational and infrastructure priorities. The answer cannot be to create an entirely separate security architecture every time a new technology appears; the better answer is to make existing controls extensible to the next identity and use case.
St. Luke’s University Health Network as an AI Agent Identity Microsegmentation Case Study
St. Luke’s environment included 15 hospitals, 85,000 production devices and 23,000 active users. After years of trying to solve segmentation through VLANs and firewalls, alternatives included re-IPing older devices, building another network, or undertaking a lengthy consultant-led deployment. “We had been at this for ten years. We weren’t going to spend another ten,” said Daniel Dopsovic, a senior enterprise information security architect at St. Luke’s. Converting roughly 500 PACS workstations the old way had already taken well past six months.
How the Deployment Actually Worked
St. Luke’s deployed Elisity on the network infrastructure it already owned, with no endpoint agent to install, no new hardware and no re-IPing. Elisity classified devices by what they were rather than where they sat on the network, and the team could observe what a policy would block before enforcing it. After about a month of preparation, the major segmentation buckets were in place in roughly 46 days, without network downtime.
Reducing Blast Radius Through AI Agent Identity Microsegmentation
Dopsovic described the old environment plainly: “One bad day on one device could take the rest of us down with it.” The goal was to reduce that blast radius so a compromised identity or device could reach only the small set of systems it legitimately needed. That also meant the organization could move faster on clinical technology, with surgical robots coming online after the physician group and surgical staff had been waiting two years for them.
Where Segmentation’s Responsibility Ends
That same architecture places a boundary around an AI agent, but that boundary matters only for what the agent can reach. Segmentation decides which paths exist; it doesn’t decide what happens on a path that’s already authorized. If an agent is legitimately allowed to reach the EHR and then behaves incorrectly inside the application, that’s not a segmentation failure, that’s where application controls, monitoring, detection and AI governance have to take over.
What This AI Agent Identity Microsegmentation Approach Means Going Forward
Given Elrod’s framing that organizations already skilled at constraining nurses, workloads, vendors, and unpatchable medical devices have “much less left to build” for AI agents, health systems evaluating their own AI security posture may find more immediate value in extending existing microsegmentation investments than in building entirely separate AI-specific security architectures. Given that St. Luke’s completed its major segmentation deployment in roughly 46 days without network downtime, this case study offers a concrete timeline benchmark for health systems of comparable scale considering similar projects.
What to Watch Going Forward
As more health systems weigh how to govern AI agents’ network access, industry observers will likely watch whether identity-based microsegmentation approaches like the one described here gain broader adoption as a complement to, rather than a replacement for, application-level AI governance and monitoring. Given that this piece is sponsored content from a vendor whose product is the featured solution, health systems evaluating AI agent identity microsegmentation options should weigh this case study alongside independent security research and competing vendor solutions before making procurement decisions.
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.
